Cormorant Asset Management sells over $2.7 million in Immuneering Corp shares By Investing.com
[ad_1] © Reuters. Cormorant Asset Management, LP, along with its associated entities, has recently sold a significant amount of Immuneering Corp (NASDAQ:IMRX) stock, according to...
Immuneering stock target cut to $15 by Needham By Investing.com
[ad_1] © Reuters. On Friday, Needham revised its price target for Immuneering Corporation (NASDAQ:IMRX), reducing it to $15.00 from the previous $20.00, while maintaining a...